Diagnostic Oncology
-
VERITAS Data Demonstrate Noninferiority of Navigational Bronchoscopy Compared to Transthoracic Needle Biopsy
Drs. James Katsis and William Thinnes say the safety profile and ability to stage lung cancer with a single procedure make a bronchoscopic approach the preferred method for lung nodule biopsy.
-
Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds
Researchers evaluating the clinical significance of IASLC-proposed criteria found the recommendations better align with clinicopathologic risk factors and improve prognostication.
-
New Data Support Continued Use of IASLC Staging Model for Mesothelioma
A multivariate analysis presented by Dr. Andrea Wolf during the World Conference on Lung Cancer shows IASLC models performed well compared to other models. However, there is room for improvement, she said.
-
Histologic Evaluation of Lung Cancer Invasion: More Difficult Than Meets the Eye
IASLC Pathology Committee members say the identification and evaluation of features that result in discordance in measuring invasive tumor size will hopefully improve reproducibility and lead to more accurate tumor staging moving forward.
-
Optimal Pathologic Staging of Lung Cancer Depends on More Than the Pathologist
Pathology—and pathologic staging in particular—can be improved through multidisciplinary efforts.
-
Low-Dose CT, ctDNA May Partner for Lung Cancer Detection
Liquid biopsy tool may be useful in high-risk individuals unwilling or unable to undergo LDCT.
-
Award Lecture Highlights Tumor Evolution Through Liquid Biopsy
The UK’s Dr. Charles Swanton received the ISLB’s 2021 award for outstanding scientific contribution.
-
Enhancing Understanding of Testing Applications, Best Practices: A Q&A with Dr. Lynette M. Sholl
Lynette M. Sholl, MD, Chief of Thoracic Pathology and Associate Director of the Center for Advanced Molecular Diagnostics at Brigham and Women’s Hospital and Associate Professor at Harvard Medical School, […]
-
IASLC GENERAL DISCLAIMER
All information and materials presented on or through IASLC’s websites, or made available or provided by or on behalf of IASLC during any webinar, seminar, or other event or activity, […]
-
Multidisciplinary EURACAN/IASLC Proposal for Revision of the Histologic Classification of Malignant Pleural Mesothelioma
Sponsored by EURACAN and the IASLC, a multidisciplinary group comprised of pathologists, oncologists, surgeons, radiologists, and molecular biologists met July 5 and 6, 2018, to critically review the current histologic […]
View ILCN Archives
Provider Resources